Evidence supporting the use of: Marine lipid (unspecified)
For the health condition: Migraine

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Marine lipids, primarily in the form of omega-3 fatty acids such as EPA and DHA (commonly found in fish oil), have been investigated for their potential role in migraine prevention and management. Several clinical studies and systematic reviews have explored the anti-inflammatory effects of omega-3s, as inflammation is believed to contribute to migraine pathophysiology. Some randomized controlled trials have shown that supplementation with omega-3 fatty acids may modestly reduce the frequency, duration, or severity of migraine attacks in certain individuals, though findings are not universally consistent.

A 2018 systematic review and meta-analysis, for example, suggested that omega-3 supplementation could reduce the frequency of migraine attacks, but the overall effect size was small and the quality of evidence was low to moderate. The mechanism is thought to involve a shift in the balance of pro-inflammatory and anti-inflammatory eicosanoids, as well as modulation of neuronal excitability and vascular function.

However, guidelines from major headache societies do not currently recommend marine lipids as a first-line therapy for migraines, and more robust, large-scale studies are needed to confirm their efficacy. In summary, while there is some scientific evidence supporting the use of marine lipids for migraine, it is limited and not definitive, so the strength of evidence is rated as 2 out of 5.

More about Marine lipid (unspecified)
More about Migraine

Products containing Marine lipid (unspecified)

We currently have no products on Vitabase that contain this ingredient.